Nabis Holdings Issues Letter to Shareholders

Comment Cannabisradar.info: The issuance of an extensive letter to all stakeholders / shareholders confirms our thesis, that the company fires on all cylinders to execute their impressive growth strategy going forward into 2020 and beyond. The letter includes an update about acquistions and activity in several us states. Nabis Holdings Issues Letter to Shareholders Download

Nabis Holdings Signs Definitive Agreement to Acquire Vertically Integrated Assets in Arizona

Comment Cannabisradar.info: Another strong acquisition of Nabis Holdings, which expands the product portfolio and significantly increases the Group’s sales. The audited revenues of the acquisition target are $ 7.4 million in 2017 and $ 8.7 million in 2018. Unaudited revenue for 2019 is $ 9 million.   Nabis Holdings Signs Definitive Agreement to Acquire Vertically

GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2019

06.08.2019   GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2019     – Epidiolex U.S. Q2 net sales of $68.4 million – – Positive CHMP opinion clears way for an expected European approval in October – – Conference call today at 4:30 p.m. EST – CARLSBAD,

Aurora Cannabis Selected as Sole Winner in Italian Cannabis Tender

18.07.2019   Aurora Cannabis Selected as Sole Winner in Italian Cannabis Tender Secures Two-Year Contract to Continue to Supply Italy with high-quality medical cannabis  NYSE: ACB  TSX:ACB EDMONTON, July 18, 2019 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today that

Pivot Pharma Strengthens Executive Leadership

——————————————————————————————————— Comment Cannabisradar-Editorial staff July 9, 2019: Nowhere else you could have made so much money in the last 12 months as in the cannabis sector! Anyone who has missed these wins so far now has a unique opportunity to be a part of PIVOT Pharmaceuticals right from the start! Now Pivot Pharmaceuticals has made

Canopy Growth Announces Leadership Transition

  Canopy Growth Announces Leadership Transition   Jul 03, 2019 By Communications Bruce Linton to step down as co-CEO and Canopy Board member Mark Zekulin remains CEO Company Launches Search to Identify Leader to Guide Next Phase of Growth TORONTO & SMITHS FALLS, ONTARIO — Today, Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED,

We found a new portfolio star! Invest now right from the start! Famous branding expert supports this cannabis company!

How about if you can invest right at the very beginning of a mega-profit opportunity in the cannabis sector? – We expect this stock will get us huge profits in this global cannabis boom! The unique patent portfolio, network and visionary management / consulting team makes PIVOT Pharmaceuticals an extremely promising top investment! More background